MAPK3 and breast cancer: MiR-550a-3p also plays its tumor-suppressor role by directly repressing ERK1 and ERK2 protein expression, thereby suppressing the oncogenic ERK/RSK cascade to reduce breast cancer cell viability, survival, migration, invasion, tumorigenesis, and metastasis (55).